Engineered T Cell Therapies from a Drug Development Viewpoint

by Fang Chen, Joseph A. Fraietta, Carl H. June, Zhongwei Xu, J. Joseph Melenhorst, Simon F. Lacey
Published 2019-02-01

CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success

by Kristen B. Long, Regina M. Young, Regina M. Young, Alina C. Boesteanu, Megan M. Davis, Megan M. Davis, J. Joseph Melenhorst, J. Joseph Melenhorst, J. Joseph Melenhorst, Simon F. Lacey, Simon F. Lacey, Simon F. Lacey, David A. DeGaramo, Bruce L. Levine, Bruce L. Levine, Joseph A. Fraietta, Joseph A. Fraietta, Joseph A. Fraietta
Published 2018-12-01

Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.

by Joseph A Fraietta, Yvonne M Mueller, Guibin Yang, Alina C Boesteanu, Donald T Gracias, Duc H Do, Jennifer L Hope, Noshin Kathuria, Shannon E McGettigan, Mark G Lewis, Luis D Giavedoni, Jeffrey M Jacobson, Peter D Katsikis
Published 2013-01-01

The Transcription Factor T-Bet Is Regulated by MicroRNA-155 in Murine Anti-Viral CD8+ T Cells via SHIP-1

by Jennifer L. Hope, Jennifer L. Hope, Christopher J. Stairiker, Christopher J. Stairiker, Panagiota I. Spantidea, Donald T. Gracias, Alison J. Carey, Alison J. Carey, Adam J. Fike, Marjan van Meurs, Inge Brouwers-Haspels, Laurine C. Rijsbergen, Joseph A. Fraietta, Yvonne M. Mueller, Rosemarieke C. Klop, Erietta Stelekati, E. John Wherry, Stefan J. Erkeland, Peter D. Katsikis
Published 2017-12-01